Immune responses in the absence of costimulation: viruses know the trick - PubMed (original) (raw)
. 1998 Dec 1;161(11):5791-4.
Affiliations
- PMID: 9834052
Immune responses in the absence of costimulation: viruses know the trick
M F Bachmann et al. J Immunol. 1998.
Abstract
Costimulatory molecules are crucial for the induction of immune responses after immunization with purified proteins or peptides. However, some viruses and other pathogens are able to induce protective immunity in the absence of such molecules. This review argues that patterns recognized by both the specific and the innate immune system, together with a high and sustained Ag-load, are responsible for these surprisingly efficient immune responses triggered by pathogens.
Similar articles
- The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens.
Bachmann MF, Nitschke L, Krawczyk C, Tedford K, Ohashi PS, Fischer KD, Penninger JM. Bachmann MF, et al. J Immunol. 1999 Jul 1;163(1):137-42. J Immunol. 1999. PMID: 10384109 - Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
Allen SD, Rawale SV, Whitacre CC, Kaumaya PT. Allen SD, et al. J Pept Res. 2005 Jun;65(6):591-604. doi: 10.1111/j.1399-3011.2005.00256.x. J Pept Res. 2005. PMID: 15885118 Review. - Costimulatory molecules and T-cell-B-cell interactions.
Crow MK. Crow MK. Rheum Dis Clin North Am. 2004 Feb;30(1):175-91, vii-viii. doi: 10.1016/S0889-857X(03)00111-X. Rheum Dis Clin North Am. 2004. PMID: 15061574 Review. - Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L, Bordenave G. Majlessi L, et al. Arch Immunol Ther Exp (Warsz). 2001;49(6):407-15. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11814234 Review. - Antibodies and B cell memory in viral immunity.
Dörner T, Radbruch A. Dörner T, et al. Immunity. 2007 Sep;27(3):384-92. doi: 10.1016/j.immuni.2007.09.002. Immunity. 2007. PMID: 17892847 Review.
Cited by
- RNA Phage VLP-Based Vaccine Platforms.
Peabody DS, Peabody J, Bradfute SB, Chackerian B. Peabody DS, et al. Pharmaceuticals (Basel). 2021 Aug 4;14(8):764. doi: 10.3390/ph14080764. Pharmaceuticals (Basel). 2021. PMID: 34451861 Free PMC article. Review. - Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.
Moradi Vahdat M, Hemmati F, Ghorbani A, Rutkowska D, Afsharifar A, Eskandari MH, Rezaei N, Niazi A. Moradi Vahdat M, et al. Biotechnol Rep (Amst). 2021 Feb 28;29:e00605. doi: 10.1016/j.btre.2021.e00605. eCollection 2021 Mar. Biotechnol Rep (Amst). 2021. PMID: 33732633 Free PMC article. Review. - Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies.
Doevendans E, Schellekens H. Doevendans E, et al. Antibodies (Basel). 2019 Mar 5;8(1):21. doi: 10.3390/antib8010021. Antibodies (Basel). 2019. PMID: 31544827 Free PMC article. Review. - Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.
Fernandez-Ruiz D, Lau LS, Ghazanfari N, Jones CM, Ng WY, Davey GM, Berthold D, Holz L, Kato Y, Enders MH, Bayarsaikhan G, Hendriks SH, Lansink LIM, Engel JA, Soon MSF, James KR, Cozijnsen A, Mollard V, Uboldi AD, Tonkin CJ, de Koning-Ward TF, Gilson PR, Kaisho T, Haque A, Crabb BS, Carbone FR, McFadden GI, Heath WR. Fernandez-Ruiz D, et al. J Immunol. 2017 Dec 15;199(12):4165-4179. doi: 10.4049/jimmunol.1700186. Epub 2017 Oct 30. J Immunol. 2017. PMID: 29084838 Free PMC article. - Virus-like particles as universal influenza vaccines.
Kang SM, Kim MC, Compans RW. Kang SM, et al. Expert Rev Vaccines. 2012 Aug;11(8):995-1007. doi: 10.1586/erv.12.70. Expert Rev Vaccines. 2012. PMID: 23002980 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources